In fact, a significant proportion of GATA2 deficient patients experience lung involvement, with manifestations such as pulmonary alveolar proteinosis (PAP) and pulmonary arterial hypertension (PAH) being observed, and small nodules and reticular infiltrates being common findings on thoracic CT imaging. This evidence concerns the gene GATA2 and pulmonary arterial hypertension.